Eric Moissenot News Today

+ Ecully, September 6, 2023 RESULTS AS OF JUNE 30, 2023 PCAS , a specialist in developing and producing complex molecules for life sciences and innovative technologies, has announced the...

Ecully, July 27, 2023 NET SALES AS OF JUNE 30, 2023 PCAS , a specialist in developing and producing complex molecules for life sciences and innovative technologies, has announced the...

Ecully, May 25th, 2023 PCAS to sell its Canadian subsidiary, PCAS Canada Inc., to DIC Corporation PCAS (Euronext Paris: PCA), specialized in the...

Ecully, May 2nd, 2023 PCAS enters into exclusive negotiations with DIC Corporation following receipt of an offer for the acquisition of its Canadian subsidiary, PCAS Canada Inc. PCAS , specialized... | May 2, 2023

Ecully, April 24, 2023 NET SALES AS OF MARCH 31, 2023 PCAS , a specialist in developing and producing complex molecules for life sciences and innovative technologies, has announced the publication... | April 24, 2023

Ecully, March 30, 2023 2022 ANNUAL RESULTS PCAS , a specialist in developing and producing complex molecules for life sciences and innovative technologies, has announced the... | March 30, 2023

Ecully, December 21, 2022 The PCAS Board of Directors met on December 20, 2022. During this meeting, the Board of Directors focused on the difficulties...

Results The PCAS Group has generated consolidated net sales of €194.1 million in fiscal year 2020, a decrease of 3.4% (-2.7% at constant exchange rates) compared to fiscal year 2019. The EBITDA amounted to €10.7 million, compared to €16.3 million in 2019 (i.e. a margin of 5.5% versus 8.1% in 2019) and was primarily impacted negatively by the delay in commissioning the new production unit at the Villeneuve-la-Garenne site, the significant drop in demand for Lubricants linked to the coronav...